Review in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Alexa H BeachumQuantitative Biomedical Research Center, Department of Health Data Science & Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, United States.
Xue XiaoQuantitative Biomedical Research Center, Department of Health Data Science & Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, United States.
Yuansheng ZhouQuantitative Biomedical Research Center, Department of Health Data Science & Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, United States.
Qiwei LiDepartment of Mathematical Sciences, The University of Texas at Dallas, 800 W. Campbell Road, Richardson, TX 75080, United States.ORCID 0000-0002-1020-3050
Guanghua XiaoQuantitative Biomedical Research Center, Department of Health Data Science & Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, United States.ORCID 0000-0001-9387-9883
Lin XuQuantitative Biomedical Research Center, Department of Health Data Science & Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, United States.ORCID 0000-0001-5815-4457
Funding
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Kathryn Ann O'Donnell · 2010 to 2026
$53.7M
Multiscale functional characterization of genomic variation in human developmental disordersUM1HG011996 · NHGRI · UT SOUTHWESTERN MEDICAL CENTER · PI Gary Chung Hon, WILLIAM Lee KRAUS · 2021 to 2026
$10.5M
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.R01DK127037 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI NOAH Freeman SHROYER, Ergun Sahin · 2022 to 2026
$3.3M
Unraveling ApoE4 Promotion of Cardiometabolic DiseaseR01HL144969 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAUL, PHILIP W · 2020 to 2023
$2.6M
Novel computational approaches to predict drug response and combination effectsR35GM136375 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2020 to 2024
$2.0M
Reprogramming myeloid cells to inhibit cancer developmentR01CA263079 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHENGCHENG ZHANG · 2022 to 2026
$1.9M
Identifying neuroblastoma drivers and bringing them to the clinicR21CA259771 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SKAPEK, STEPHEN X, XU, LIN · 2021 to 2021
$437k
Cancer Prevention and Research Institute of Texas RP170152Cancer Prevention and Research Institute of Texas RP180319Cancer Prevention and Research Institute of Texas RP180805Cancer Prevention and Research Institute of Texas RP190107Cancer Prevention and Research Institute of Texas RP200103Cancer Prevention and Research Institute of Texas RP220032Children's Cancer FundNCI NIH HHS P30 CA142543NIH HHS 1R01GM115473NIH HHS 1R01GM140012NIH HHS 5R01CA152301NIH HHS P30CA142543NIH HHS P50CA70907NIH HHS R01CA263079NIH HHS R01DK127037NIH HHS R01HL144969NIH HHS R21CA259771NIH HHS R35GM136375NIH HHS UM1HG011996Rally FoundationSam Day Foundation
6 · The paper itself
Abstract
While traditional imaging techniques, such as histopathology, are often part of clinical workflows, molecular profiling remains more difficult to conduct and is less cost-effective. Thus, the prediction of molecular 'omics' data directly from imaging has emerged as an appealing alternative. While existing reviews have mentioned image-based prediction of biomarkers within specific disease contexts, this review provides a comprehensive overview of current methods that leverage imaging to predict (i) DNA-based aberrations, (ii) bulk transcriptomic profiles, (iii) single-cell transcriptomics, and (iv) spatial transcriptomics across disease contexts and imaging modalities. To address the complexity of these predictive tasks, we find that many studies employ cutting-edge deep learning strategies for image processing, feature extraction, feature aggregation, and downstream molecular prediction. In this review, we highlight the diverse applications of both deep learning-based and modern statistical frameworks designed for image-based omics prediction. The insights gleaned from these inferred molecular data have broad clinical relevance and will continue to improve our understanding of the relationships between molecular and visual features, paving the way for new diagnostic and therapeutic applications.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Advances in predicting omics profiles from imaging data. · full record | OpenQuestion